DU PONT E I DE NEMOURS & CO INC -- SUVA MP39 (R401A) -- 6830-00D006819
===================== Product Identification ===================== Product ID:SUVA MP39 (R401A) MSDS Date:10/05/1996 FSC:6830 NIIN:00D006819 === Responsible Party === Company Name:DU PONT E I DE NEMOURS & CO INC Address:1007 MARKET STREET Box:1635 City:WILMINGTON State:DE ZIP:19898 Country:US Info Phone Num:800-441-7515/MSDS 302-992-3511 Emergency Phone Num:800-441-3637/800-424-9300(CHEMTREC) Preparer's Name:DUPONT CHEMICALS CAGE:18873 === Contractor Identification === Company Name:DU PONT FLUOROPRODUCTS Address:1007 MARKET STREET Box:City:WILMINGTON State:DE ZIP:19898 Country:US Phone:1-800-441-7515 CAGE:2S827 Company Name:E.I. DUPONT DE NEMOURS & CO Address:1007 MARKET STREET Box:City:WILMINGTON State:DE ZIP:19898 Country:US Phone:800-441-7515;800-441-9442 CAGE:18873 ============= Composition/Information on Ingredients ============= Ingred Name:CHLORODIFLUOROMETHANE (SARA 313) (CERCLA) CAS:75-45-6 RTECS #:PA6390000 Fraction by Wt: 53% Other REC Limits:NONE RECOMMENDED OSHA PEL:1000 PPM ACGIH TLV:1000 PPM; 9596 Ozone Depleting Chemical:2 Ingred Name:1,1DIFLUOROETHANE CAS:75-37-6 RTECS #:KI1410000 Fraction by Wt: 13% Other REC Limits:NONE RECOMMENDED Ingred Name:2-CHLORO-1,1,1,2-TETRAFLUOROETHANE (SARA 313) CAS:2837-89-0 Fraction by Wt: 34% Other REC Limits:NONE RECOMMENDED ===================== Hazards Identification ===================== LD50 LC50 Mixture:AEL DUPONT: 1000 PPM 8 & 12 HR TWA Routes of Entry: Inhalation:YES Skin:YES Ingestion:NO Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO Health Hazards Acute and Chronic:INHALATION OF HIGH CONCENTRATIONS OF VAPOR IS HARMFUL & MAY CAUSE HEART IRREGULARITIES, UNCONSCIOUSNESS, OR DEATH. INTENTIONAL MISUES OR DELIBERATE INHALATION MAY CAUSE DEATH WITHOUT WARNING. VAPOR RE DUCES OXYGEN AVAILABLE FOR BREATHING AND IS HEAVIER THAN AIR. LIQUID CONTACT CAN CAUSE FROSTBITE. Explanation of Carcinogenicity:NO INGREDIENT OF A CONCENTRATION OF 0.1% OR GREATER IS LISTED AS A CARCINOGEN OR SUSPECTED CARCINOGEN. Effects of Overexposure:SKIN CONTACT MAY CAUSE FROSTBITE FROM EXPOSURE TO THE LIQUID. INHALATION MAY INCLUDE NONSPECIFIC DISCOMFORT, SUCH AS NAUSEA, HEADACHE, OR WEAKNESS OR TEMPORARY NERVOUS SYSTEM DEPRESSION WITH ANESTHETI C EFFECTS SUCH AS DIZZINESS, HEADACHE, CONFUSION, INCOORDINATION AND LOSS OF CONSCIOUSNESS. Medical Cond Aggravated by Exposure:NONE SPECIFIED BY MANUFACTURER. ======================= First Aid Measures ======================= First Aid:INHALATION: REMOVE TO FRESH AIR. KEEP PERSON CALM, IF NOT BREATHING, GIVE ARTIFICIAL RESPIRATION. IF BREATHING IS DIFFICULT, GIVE OXYGEN. SKIN: FLUSH W/WATER TREAT FOR FROSTBITE IF NECESSARY BY GENTLY WARMING AFFECTED AREA. EYES: FLUSH W/PLENTY OF WATER FOR 15 MINUTES. OBTAIN MEDICAL ATTENTION IN ALL CASES. ===================== Fire Fighting Measures ===================== Flash Point Method:TOC Flash Point:WILL NOT BURN Autoignition Temp:Autoignition Temp Text:681C Lower Limits:NONE Upper Limits:NONE Extinguishing Media:USE MEDIA APPROPRIATE FOR SURROUNDING MATERIAL. Fire Fighting Procedures:WEAR SELF-CONTAINED BREATHING APPARATUS AND FULL FIRE FIGHTER'S PROTECTIVE GEAR. USE WATER TO COOL FIRE EXPOSED CONTAINERS. Unusual Fire/Explosion Hazard:CYLINDERS MAY RUPTURE UNDER FIRE CONDITIONS. DECOMPOSITION MAY OCCUR. ================== Accidental Release Measures ================== Spill Release Procedures:VENTILATE AREA, ESPECIALLY LOW/ENCLOSED PLACES WHERE HEAVY VAPORS MIGHT COLLECT. REMOVE OPEN FLAMES. USE SELF- CONTAINED BREATHING APPARATUS IF LARGE SPILL OR LEAK OCCURS. Neutralizing Agent:NONE SPECIFIED BY MANUFACTURER. ====================== Handling and Storage ====================== Handling and Storage Precautions:STORE IN A CLEAN, DRY PLACE. DO NOT HEAT ABOVE 52C (126F). Other Precautions:AVOID BREATHING VAPORS OR MIST. AVOID CONTACT WITH EYES OR SKIN. USE WITH SUFFCIENT VENTILATION TO KEEP EMPLOYEE EXPOSURE BELOW THE RECOMMENDED LIMIT. ============= Exposure Controls/Personal Protection ============= Respiratory Protection:UNDER NORMAL MANUFACTURUNG CONDITIONS, NO RESPIRATORY PROTECTION IS REQUIRED WHEN USING THIS PRODUCT. SELF-CONTAINED BREATHING APPARATUS IS REQUIRED IF LARGE RELEASE OCCURS. Ventilation:LOCAL EXHAUST IF LARGE AMOUNTS ARE RELEASED. MECHANICAL VENTILATION SHOULD BE USEDD IN LOW/ENCLOSED PLACES. Protective Gloves:LINED BUTYL GLOVES. Eye Protection:CHEMICAL SPLASH GOGGLES. Other Protective Equipment:NONE SPECIFIED BY MANUFACTURER. Work Hygienic Practices:WASH CONTAMINATED CLOTHING BEFORE REUSE. Supplemental Safety and Health NOTE TO PHYSICIAN: BECAUSE OF POSSIBLE DISTURBANCES OF CARDIAC RHYTHM, CATECHOLAMINE DRUGS, SUCH AS EPINEPHRINE, SHOULD ONLY BE USED WITH SPECIAL CAUTION. ================== Physical/Chemical Properties ================== HCC:G3 Boiling Pt:B.P. Text:-27F,-33C Vapor Pres:5798 Vapor Density:3.3 Evaporation Rate & Reference:>1 (CCL4=1.0) Solubility in Water:NEGLIGIBLE, 0.1% Appearance and Odor:CLEAR, COLORLESS LIQUIFIED GAS, ETHER (SLIGHT) ODOR. Percent Volatiles by Volume:100 ================= Stability and Reactivity Data ================= Stability Indicator/Materials to Avoid:YES INCOMPATIBLE W/ALKALI OR ALKALINE EARTH METALS- POWEDERED AL, ZN, BE, ETC. Stability Condition to Avoid:AVOID OPEN FLAMES AND HIGH TEMPERATURES. Hazardous Decomposition Products:HYDROCHLORIC AND HYDROFLUORIC ACIDS & POSSIBLE CARBONYL HALIDES. Conditions to Avoid Polymerization:POLYMERIZATION WILL NOT OCCUR. ==================== Disposal Considerations ==================== Waste Disposal Methods:COMPLY WITH FEDERAL, STATE & LOCAL REGULATIONS FOR REPORTING RELEASES. Disclaimer (provided with this information by the compiling agencies): This information is formulated for use by elements of the Department of Defense. The United States of America in no manner whatsoever, expressly or implied, warrants this information to be accurate and disclaims all liability for its use. Any person utilizing this document should seek competent professional advice to verify and assume responsibility for the suitability of this information to their particular situation.